A 43-year-old man is diagnosed with chronic myeloid leukemia (CML) and started on standard imatinib therapy (tyrosine kinase inhibitor, TKI). Which of the following clinical findings indicate this therapy protocol is NOT appropriate and should be altered? O Ph+ chromosome is undetectable in bone marrow cells after 9 months of treatment. O The BCR ABL1 (fusion) to ABL1 (wild-type) expression (MRNA) ratio is significantly reduced after 3 months of treatment. O The expression (MRNA) ratio of BCR-ABL1/ABL1 is down to 0.08% after 18 months of therapy. O 1-month into therapy and the patient shows an increased frequency of bone marrow cells with the Ph+ chromosome. O His WBC counts have returned to normal levels.

Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
icon
Related questions
Question
A 43 year-old man is diagnosed with chronic myeloid leukemia (CML)
and started on standard imatinib therapy (tyrosine kinase inhibitor,
TKI). Which of the following clinical findings indicate this therapy
protocol is NOT appropriate and should be altered?
O Ph+ chromosome is undetectable in bone marrow cells after 9 months of treatment.
O The BCR ABL1 (fusion) to ABL1 (wild-type) expression (MRNA) ratio is significantly
reduced after 3 months of treatment.
O The expression (mRNA) ratio of BCR-ABL1/ABL1 is down to 0 08% after 18 months
of therapy
O 1-month into therapy and the patient shows an increased frequency of bone marrow
cells with the Ph+ chromosome
O His WBC counts have returned to normal levels.
Transcribed Image Text:A 43 year-old man is diagnosed with chronic myeloid leukemia (CML) and started on standard imatinib therapy (tyrosine kinase inhibitor, TKI). Which of the following clinical findings indicate this therapy protocol is NOT appropriate and should be altered? O Ph+ chromosome is undetectable in bone marrow cells after 9 months of treatment. O The BCR ABL1 (fusion) to ABL1 (wild-type) expression (MRNA) ratio is significantly reduced after 3 months of treatment. O The expression (mRNA) ratio of BCR-ABL1/ABL1 is down to 0 08% after 18 months of therapy O 1-month into therapy and the patient shows an increased frequency of bone marrow cells with the Ph+ chromosome O His WBC counts have returned to normal levels.
Expert Solution
steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Genomic studies
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education